puromycin aminonucleoside has been researched along with Nephrosis, Lipoid in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (30.30) | 18.7374 |
| 1990's | 9 (27.27) | 18.2507 |
| 2000's | 1 (3.03) | 29.6817 |
| 2010's | 11 (33.33) | 24.3611 |
| 2020's | 2 (6.06) | 2.80 |
| Authors | Studies |
|---|---|
| Ashida, A; Fujii, Y; Matsumura, H; Nakakura, H; Ogihara, T; Shirasu, A; Yamazaki, S | 1 |
| Chen, J; Feng, S; Jiang, H; Li, B; Lin, C; Lin, W; Shao, X; Shen, X; Wang, C; Wang, H; Wang, Y; Weng, C; Zhang, Y | 1 |
| Hong, Y; Sun, W; Wang, J; Xu, X; Zhang, K; Zhang, L | 1 |
| Abe, M; Kawasaki, Y; Natori, Y; Sugiyama, A; Yonezawa, S | 1 |
| Fukusumi, Y; Kawachi, H; Kayaba, M; Kitazawa, Y; Takahashi, A; Tomita, M; Yamazaki, M | 1 |
| Chan, KW; Kang, YL; Law, HK; Saleem, MA; Yung, BY | 1 |
| Fukusumi, Y; Ito, E; Kaneko, H; Kawachi, H; Matsui, K; Suzuki, K; Tanaka, H; Tsuruga, K; Yamazaki, M | 1 |
| Eriguchi, M; Hasegawa, S; Kawai, Y; Kitazono, T; Masutani, K; Noguchi, H; Tanaka, S; Torisu, K; Tsuruya, K; Yotsueda, R | 1 |
| Andreoli, SP | 1 |
| Bi, Y; Chen, J; Feng, S; Huang, X; Jiang, H; Lan, HY; Li, M; Li, X; Lin, C; Lin, W; Shen, J; Shen, X; Wang, H; Wang, L; Wang, Y; Weng, C; Xie, Z; Ying, M; Zhao, J; Zhou, J; Zhou, Q; Zhu, T | 1 |
| Fujimoto, S; Fukuda, A; Iwatsubo, S; Kawachi, H; Kitamura, K | 1 |
| Dong, C; Feng, BF; Gao, LL; Guan, FJ; Yang, HD; Zhao, T | 1 |
| Baumann, M; Fuchshofer, R; Junglas, B; Tamm, ER; Ullmann, S; Zeilbeck, LF | 1 |
| Lewis, EJ; Pauli, BU; Schwartz, MM; Sharon, Z | 1 |
| Fujiwara, Y | 1 |
| Okamoto, M | 1 |
| Abrahamson, DR; Caulfield, JP; Hein, A | 1 |
| Furness, PN; Harris, K | 1 |
| Nakai, Y; Yamane, H | 1 |
| Ebihara, I; Fukui, M; Koide, H; Nakamura, T; Takahashi, T; Tomino, Y | 1 |
| Gomi, H; Ishimoto, F; Matsuda, H; Sakai, O; Shibasaki, T; Usui, M | 1 |
| Evans, GO; Goodwin, DA; Hawksworth, GM; Hodgson, ST; Morley, TJ; Read, NG | 1 |
| Hanada, S; Maruyama, T; Matsui, T; Nakamura, N; Shintome, M; Tsuchiyama, H; Tsukada, M; Yuki, T | 1 |
| Amano, O; Fan, L; Iseki, S; Wakayama, T; Yokoyama, S | 1 |
| Baylis, C; Bohrer, MP; Brenner, BM; Robertson, CR; Troy, JL; Willis, WT | 1 |
| Ebihara, I; Fukui, M; Koide, H; Nakamura, T; Tomino, Y | 1 |
| Tanabe, T | 1 |
| Diamond, JR; Hanchak, NA; Karnovsky, MJ; McCarter, MD | 1 |
| Adu, D; Beaman, M; MacLennan, IC; Michael, J; Oldfield, S | 1 |
| Eddy, AA; Michael, AF | 1 |
| Asakura, S; Asano, Y; Kato, K; Taki, Y; Terukina, S | 1 |
| Allen, J; Conklin, S; Fan, J; Lan, YH; Nguyen, D; Reineck, S; Spear, GS; Wikle, JS | 1 |
| Davies, DJ; Dillane, PC; Messina, A; Ryan, GB | 1 |
1 review(s) available for puromycin aminonucleoside and Nephrosis, Lipoid
| Article | Year |
|---|---|
An evaluation of experimental models of glomerulonephritis.
Topics: Animals; Antigen-Antibody Complex; Autoimmune Diseases; Disease Models, Animal; Evaluation Studies as Topic; Glomerulonephritis; Glomerulonephritis, IGA; Glomerulosclerosis, Focal Segmental; Humans; Mice; Nephrosis, Lipoid; Puromycin Aminonucleoside; Serum Sickness; Species Specificity | 1994 |
32 other study(ies) available for puromycin aminonucleoside and Nephrosis, Lipoid
| Article | Year |
|---|---|
Efficacy of a mitochondrion-targeting agent for reducing the level of urinary protein in rats with puromycin aminonucleoside-induced minimal-change nephrotic syndrome.
Topics: Animals; Antioxidants; Drug Delivery Systems; Lipid Peroxidation; Male; Mitochondria; Nephrosis, Lipoid; Organophosphorus Compounds; Oxidative Stress; Piperidines; Podocytes; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Wistar | 2020 |
Calcineurin inhibitors ameliorate PAN-induced podocyte injury through the NFAT-Angptl4 pathway.
Topics: Angiopoietin-Like Protein 4; Animals; Calcineurin Inhibitors; Case-Control Studies; Cells, Cultured; Glomerulonephritis, Membranous; Humans; Male; Mice; Nephrosis, Lipoid; NFATC Transcription Factors; Podocytes; Proteinuria; Puromycin Aminonucleoside; Rats; Signal Transduction | 2020 |
miR-499 Ameliorates Podocyte Injury by Targeting Calcineurin in Minimal Change Disease.
Topics: Animals; Calcineurin; Cell Line; Lentivirus; Mice, Inbred C57BL; MicroRNAs; Nephrosis, Lipoid; Podocytes; Puromycin Aminonucleoside; Random Allocation | 2018 |
Each liver X receptor (LXR) type has a different purpose in different situations.
Topics: Animals; Cell Line; Disease Models, Animal; Gene Knockdown Techniques; Kidney; Lipid Metabolism; Liver X Receptors; Male; Nephrosis, Lipoid; Puromycin Aminonucleoside; Rats; Rats, Wistar; RNA, Messenger | 2019 |
Angiotensin II type 1 receptor blockade ameliorates proteinuria in puromycin aminonucleoside nephropathy by inhibiting the reduction of NEPH1 and nephrin.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Biphenyl Compounds; Disease Models, Animal; Disease Progression; Female; Gene Expression Regulation; Intracellular Signaling Peptides and Proteins; Irbesartan; Kidney Glomerulus; Membrane Proteins; Nephrosis, Lipoid; Proteinuria; Puromycin Aminonucleoside; Rats, Wistar; Receptor, Angiotensin, Type 1; Tetrazoles; Time Factors | 2014 |
Trehalose, an mTOR independent autophagy inducer, alleviates human podocyte injury after puromycin aminonucleoside treatment.
Topics: Actin Cytoskeleton; Antibiotics, Antineoplastic; Apoptosis; Autophagy; Autophagy-Related Protein 5; Blotting, Western; Cell Line; Cell Movement; Humans; Microscopy, Fluorescence; Microtubule-Associated Proteins; Nephrosis, Lipoid; Podocytes; Puromycin Aminonucleoside; Reactive Oxygen Species; TOR Serine-Threonine Kinases; Trehalose | 2014 |
Alteration in the podoplanin-ezrin-cytoskeleton linkage is an important initiation event of the podocyte injury in puromycin aminonucleoside nephropathy, a mimic of minimal change nephrotic syndrome.
Topics: Animals; Cytoskeleton; Humans; Kidney Diseases; Membrane Glycoproteins; Nephrosis, Lipoid; Podocytes; Puromycin Aminonucleoside; Rabbits; Rats | 2015 |
Assessment of urinary angiotensinogen as a marker of podocyte injury in proteinuric nephropathies.
Topics: Adult; Aged; Angiotensinogen; Animals; Antibiotics, Antineoplastic; Female; Glomerulosclerosis, Focal Segmental; Humans; Kidney; Kidney Diseases; Kidney Glomerulus; Kidney Tubules, Proximal; Male; Middle Aged; Nephrosis, Lipoid; Podocytes; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Wistar | 2016 |
50 Years Ago in The Journal of Pediatrics: Effect of Cyclophosphamide on Lipoid Nephrosis in the Human and on Aminonucleoside Nephrosis in the Rat.
Topics: Adrenal Cortex Hormones; Animals; Child; Cyclophosphamide; History, 20th Century; Humans; Nephrosis; Nephrosis, Lipoid; Pediatrics; Proteinuria; Puromycin Aminonucleoside; Rats; Recurrence; Remission Induction | 2016 |
Calcineurin inhibitors cyclosporin A and tacrolimus protect against podocyte injury induced by puromycin aminonucleoside in rodent models.
Topics: Animals; Apoptosis; Calcineurin Inhibitors; Cell Line; Cyclosporine; Male; MAP Kinase Signaling System; Mice; Nephrosis, Lipoid; Podocytes; Proteinuria; Puromycin Aminonucleoside; Rats, Sprague-Dawley; Tacrolimus | 2016 |
Effects of mineralocorticoid and angiotensin II receptor blockers on proteinuria and glomerular podocyte protein expression in a model of minimal change nephrotic syndrome.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Disease Models, Animal; Eplerenone; Fluorescent Antibody Technique; Intracellular Signaling Peptides and Proteins; Losartan; Male; Membrane Proteins; Mineralocorticoid Receptor Antagonists; Nephrosis, Lipoid; Podocytes; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley; Sialoglycoproteins; Spironolactone; Time Factors | 2010 |
[Bone mesenchymal stem cell transplantation repairs glomerular podocytes in rats with puromycin aminonucleoside-induced nephrosis].
Topics: Animals; Bromodeoxyuridine; Kidney; Male; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Nephrosis, Lipoid; Podocytes; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction | 2010 |
Connective tissue growth factor modulates podocyte actin cytoskeleton and extracellular matrix synthesis and is induced in podocytes upon injury.
Topics: Actin Cytoskeleton; Animals; Cell Death; Cells, Cultured; Connective Tissue Growth Factor; Extracellular Matrix; Glomerulosclerosis, Focal Segmental; Humans; Kidney Glomerulus; Male; Nephrosis, Lipoid; Podocytes; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Wistar; RNA Interference; RNA, Messenger; Transfection; Up-Regulation | 2011 |
Inhibition of glomerular visceral epithelial cell endocytosis during nephrosis induced by puromycin aminonucleoside.
Topics: Animals; Endocytosis; Epithelium; Fluorescent Antibody Technique; Heparin; Kidney Glomerulus; Kinetics; Male; Microscopy, Electron; Nephrosis, Lipoid; Protamines; Proteinuria; Puromycin; Puromycin Aminonucleoside; Rats; Rats, Inbred Strains | 1984 |
An ultrastructural study of the effect of the steroid in puromycin aminonucleoside nephrosis rats.
Topics: Animals; Disease Models, Animal; Kidney Glomerulus; Male; Methylprednisolone; Microscopy, Electron; Nephrosis, Lipoid; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Inbred Strains | 1984 |
[Renal hemodynamics in aminonucleoside nephrosis in rats].
Topics: Animals; Hemodynamics; Kidney Cortex; Male; Nephrosis, Lipoid; Puromycin Aminonucleoside; Rats; Rats, Inbred Strains; Renal Circulation | 1984 |
Laminin in glomerular basement membranes of aminonucleoside nephrotic rats. Increased proteinuria induced by antilaminin immunoglobulin G.
Topics: Animals; Basement Membrane; Glycoproteins; Immunoglobulin G; Kidney Glomerulus; Laminin; Male; Membrane Proteins; Nephrosis, Lipoid; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Inbred Strains | 1983 |
Inner ear damage due to lipoid nephrosis.
Topics: Animals; Cochlea; Evoked Potentials, Auditory, Brain Stem; Labyrinth Diseases; Male; Microscopy, Electron; Nephrosis, Lipoid; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley; Vestibule, Labyrinth | 1993 |
Altered glomerular steady-state levels of tumour necrosis factor-alpha mRNA during nephrotic and sclerotic phases of puromycin aminonucleoside nephrosis in rats.
Topics: Acute Disease; Animals; Kidney Glomerulus; Kidney Medulla; Male; Methylprednisolone; Nephrectomy; Nephrosis, Lipoid; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sclerosis; Tumor Necrosis Factor-alpha | 1993 |
Mizoribine reduces urinary protein excretion in rats given puromycin aminonucleoside.
Topics: Animals; Antibiotics, Antineoplastic; Immunosuppressive Agents; Male; Nephrosis; Nephrosis, Lipoid; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Wistar; Ribonucleosides; Thromboxane B2 | 1996 |
Structure-activity relationship for two lipoxygenase inhibitors and their potential for inducing nephrotic syndrome.
Topics: Administration, Oral; Animals; Antibiotics, Antineoplastic; Blood Proteins; Cholesterol; Creatinine; Disease Models, Animal; Female; Hydroxamic Acids; Hydroxyurea; Kidney Glomerulus; Lipoxygenase Inhibitors; Nephrosis, Lipoid; Nephrotic Syndrome; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Wistar; Structure-Activity Relationship; Triglycerides; Urinalysis | 1997 |
Effects of recombinant human serum albumin on ascites in rats with puromycin aminonucleoside-induced nephropathy.
Topics: Animals; Ascites; Disease Models, Animal; Diuretics; Drug Evaluation, Preclinical; Furosemide; Humans; Male; Nephrosis, Lipoid; Osmotic Pressure; Puromycin Aminonucleoside; Rats; Rats, Wistar; Recombinant Proteins; Serum Albumin | 1998 |
Downregulation of vascular endothelial growth factor and its receptors in the kidney in rats with puromycin aminonucleoside nephrosis.
Topics: Animals; Antibiotics, Antineoplastic; Disease Models, Animal; Down-Regulation; Endothelial Growth Factors; Humans; In Situ Hybridization; Kidney; Lymphokines; Male; Nephrosis, Lipoid; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley; Receptor Protein-Tyrosine Kinases; Receptors, Growth Factor; Receptors, Vascular Endothelial Growth Factor; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2002 |
Mechanisms of the puromycin-induced defects in the transglomerular passage of water and macromolecules.
Topics: Animals; Biological Transport; Blood Proteins; Dextrans; Female; Glomerular Filtration Rate; Kidney Glomerulus; Macromolecular Substances; Male; Nephrons; Nephrosis, Lipoid; Puromycin; Puromycin Aminonucleoside; Rats; Regional Blood Flow; Water; Water Deprivation | 1977 |
Effects of methylprednisolone on glomerular and medullary mRNA levels for extracellular matrices in puromycin aminonucleoside nephrosis.
Topics: Animals; Collagen; Extracellular Matrix Proteins; Gene Expression; Heparan Sulfate Proteoglycans; Heparitin Sulfate; Kidney Glomerulus; Kidney Medulla; Laminin; Male; Methylprednisolone; Nephrosis, Lipoid; Proteoglycans; Puromycin Aminonucleoside; Rats; Rats, Inbred Strains; RNA, Messenger | 1991 |
[Mechanism of reduction in proteinuria by cyclosporine A: effects on the glomerular anionic sites].
Topics: Animals; Anions; Basement Membrane; Cyclosporins; Kidney Glomerulus; Male; Nephrosis, Lipoid; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Inbred Strains | 1990 |
Cholestyramine resin ameliorates chronic aminonucleoside nephrosis.
Topics: Animals; Cholesterol; Cholestyramine Resin; Diet; Disease Models, Animal; Glomerular Filtration Rate; Hypercholesterolemia; Kidney Glomerulus; Male; Nephrosis, Lipoid; Puromycin Aminonucleoside; Rats; Rats, Inbred Strains; Triglycerides | 1990 |
Hypogammaglobulinaemia in nephrotic rats is attributable to hypercatabolism of IgG.
Topics: Agammaglobulinemia; Animals; Antibody-Producing Cells; Dinitrobenzenes; Half-Life; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Male; Nephrosis, Lipoid; Puromycin Aminonucleoside; Rats; Rats, Inbred Strains; Spleen | 1988 |
Acute tubulointerstitial nephritis associated with aminonucleoside nephrosis.
Topics: Albuminuria; Animals; Female; Histocompatibility Antigens Class II; Immunohistochemistry; Leukocytes, Mononuclear; Nephritis, Interstitial; Nephrosis, Lipoid; Puromycin; Puromycin Aminonucleoside; Rats; Rats, Inbred Lew | 1988 |
[N-acetyl-beta-D-glucosaminidase (NAG) activity and low molecular weight urinary proteins in rats with puromycin-aminonucleoside (PAN)-induced nephrosis].
Topics: Acetylglucosaminidase; Albuminuria; Animals; Female; Hexosaminidases; Kidney; Molecular Weight; Nephrosis, Lipoid; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Inbred Strains | 1987 |
DMSO potentiates aminonucleoside of puromycin nephrosis in rats.
Topics: Animals; Dimethyl Sulfoxide; Drug Synergism; Kidney; Male; Nephrosis, Lipoid; Proteinuria; Puromycin; Puromycin Aminonucleoside; Rats; Rats, Inbred Strains | 1987 |
Glomerular epithelial abnormalities associated with the onset of proteinuria in aminonucleoside nephrosis.
Topics: Animals; Epithelium; Female; Kidney Glomerulus; Microscopy, Electron; Nephrosis, Lipoid; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Inbred Strains | 1987 |